Chuan Kok Lim

1.2k total citations · 1 hit paper
23 papers, 365 citations indexed

About

Chuan Kok Lim is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Chuan Kok Lim has authored 23 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Chuan Kok Lim's work include Poxvirus research and outbreaks (7 papers), Herpesvirus Infections and Treatments (6 papers) and Bacillus and Francisella bacterial research (5 papers). Chuan Kok Lim is often cited by papers focused on Poxvirus research and outbreaks (7 papers), Herpesvirus Infections and Treatments (6 papers) and Bacillus and Francisella bacterial research (5 papers). Chuan Kok Lim collaborates with scholars based in Australia, United States and South Korea. Chuan Kok Lim's co-authors include Deborah A. Williamson, Thomas Tran, Michael R. Beard, Jonathan Gleadle, Feargal J. Ryan, Zelalem A. Mekonnen, Catherine Ferguson, Arthur Eng Lip Yeow, Pravin Hissaria and David Shaw and has published in prestigious journals such as Scientific Reports, Journal of Clinical Microbiology and The Lancet Infectious Diseases.

In The Last Decade

Chuan Kok Lim

18 papers receiving 359 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection

2022 187 citations Feargal J. Ryan, Christopher M. Hope et al. BMC Medicine profile →

Peers

Countries citing papers authored by Chuan Kok Lim

Since Specialization

Citations

This map shows the geographic impact of Chuan Kok Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan Kok Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan Kok Lim more than expected).

Fields of papers citing papers by Chuan Kok Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan Kok Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan Kok Lim. The network helps show where Chuan Kok Lim may publish in the future.

Co-authorship network of co-authors of Chuan Kok Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan Kok Lim. A scholar is included among the top collaborators of Chuan Kok Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan Kok Lim. Chuan Kok Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Laboratory biosafety risk assessment: A critical component of avian influenza preparedness 2025 ·(unknown), (unknown), Ian Barr, Chuan Kok Lim	0
2	Alternative treponemal serology assays for diagnosis and confirmation of syphilis in a diagnostic laboratory: a retrospective evaluation of four agglutination assays and one ELISA 2025 ·Journal of Clinical Microbiology ·Eloise Williams, Theo Karapanagiotidis, Suellen Nicholson, (unknown), (unknown), (unknown), (unknown), (unknown), Maryza Graham, Janet M Towns, Marcus Y. Chen, Chuan Kok Lim, Deborah A. Williamson	0
3	Anti-NMDA receptor encephalitis following Murray Valley encephalitis: a case report 2025 ·PubMed ·(unknown), Prashanth Ramachandran, John Burston, Annaleise R. Howard‐Jones, Chuan Kok Lim, Jen Kok, (unknown), (unknown), Justin Jackson	0
4	Mpox genomics in outbreak control: challenges and limitations 2024 ·The Lancet Microbe ·Kathryn Edenborough, (unknown), (unknown), (unknown), Eike Steinig, Brendan Quinn, (unknown), Alicia Arnott, Leon Caly, Chuan Kok Lim	1
5	A rise inMycoplasma pneumoniaerespiratory infections in Victoria in late 2023 and early 2024 detected at two major testing laboratories 2024 ·The Medical Journal of Australia ·Maryza Graham, Thomas Tran, (unknown), Michelle Sam, Andrew J. Daley, Kathy Merlock Jackson, Chuan Kok Lim	1
6	Laboratory diagnosis of HIV: a contemporary overview in the Australian context 2023 ·Pathology ·Eloise Williams, (unknown), Chuan Kok Lim, Doris Chibo, Suellen Nicholson, Kathy Merlock Jackson, Deborah A. Williamson	5
7	Laboratory evaluation of ELISA and indirect immunofluorescence assay in response to emergence of Japanese encephalitis virus genotype IV in Australia 2023 ·Journal of Clinical Virology ·Paul Kinsella, (unknown), Geneviève Martin, (unknown), (unknown), Suellen Nicholson, (unknown), Kathy Merlock Jackson, (unknown), (unknown), Lakshmi Manoharan, (unknown), N. Deborah Friedman, Katherine Bond, Deborah A. Williamson, Chuan Kok Lim	4
8	Intra‐ and interhost genomic diversity of monkeypox virus 2023 ·Journal of Medical Virology ·(unknown), Eike Steinig, George Taiaroa, (unknown), Thomas Tran, (unknown), Stephanie Tran, Alvin Lee, (unknown), (unknown), Eric P. F. Chow, Christopher K. Fairley, Janet M Towns, Marcus Y. Chen, Leon Caly, Chuan Kok Lim, Deborah A. Williamson	7
9	SARS-CoV-2 produces a microRNA CoV2-miR-O8 in patients with COVID-19 infection 2023 ·iScience ·Elise J. Tucker, (unknown), Shashikanth Marri, Saira Ali, Anthony O. Fedele, Michael Michael, Darling Rojas-Canales, Jordan Li, Chuan Kok Lim, Jonathan Gleadle	4
10	An integrated public health response to an outbreak of Murray Valley encephalitis virus infection during the 2022–2023 mosquito season in Victoria 2023 ·Frontiers in Public Health ·(unknown), (unknown), Chuan Kok Lim, Rebecca Feldman, (unknown), Peter J. Neville, (unknown), (unknown), (unknown), (unknown), (unknown), N. Deborah Friedman	12
11	Laboratory assessment of a multi-target assay for the rapid detection of viruses causing vesicular diseases 2023 ·Journal of Clinical Virology ·(unknown), Georgina Papadakis, (unknown), Thomas Tran, Julian Druce, Chuan Kok Lim, Deborah A. Williamson, Kathy Merlock Jackson	3
12	Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccinees and breakthrough infected individuals 2023 ·Scientific Reports ·Chee Wah Tan, Chuan Kok Lim, (unknown), (unknown), (unknown), (unknown), Lin‐Fa Wang, (unknown), Danielle E. Anderson	1
13	Evaluation of 16 molecular assays for the detection of orthopox and mpox viruses 2023 ·Journal of Clinical Virology ·Georgina Papadakis, Thomas Tran, Julian Druce, Chuan Kok Lim, Deborah A. Williamson, Kathy Merlock Jackson	15
14	Correlation between monkeypox viral load and infectious virus in clinical specimens 2023 ·Journal of Clinical Virology ·Chuan Kok Lim, (unknown), Joshua M. Deerain, Eric P. F. Chow, Janet M Towns, Marcus Y. Chen, Christopher K. Fairley, Thomas Tran, Deborah A. Williamson	33
15	Prevention and post-exposure management of occupational exposure to Ebola virus 2023 ·The Lancet Infectious Diseases ·(unknown), Chuan Kok Lim, Eloise Williams, Caroline Marshall, James McCarthy, Deborah A. Williamson	3
16	Assessment of hepatitis B virus infection and interhost cellular responses using intrahepatic cholangiocyte organoids 2023 ·Journal of Medical Virology ·Chuan Kok Lim, (unknown), (unknown), Dustin J. Flanagan, (unknown), Erin M. McCartney, Edmund Tse, Elizabeth Vincan, Michael R. Beard	2
17	Mpox diagnostics: Review of current and emerging technologies 2022 ·Journal of Medical Virology ·Chuan Kok Lim, Jason Roberts, (unknown), Kwee Chin Liew, (unknown), Eloise Williams, Thomas Tran, Eike Steinig, Leon Caly, Deborah A. Williamson	59
18	Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection breakdown → 2022 ·BMC Medicine ·Feargal J. Ryan, Christopher M. Hope, Makutiro G. Masavuli, Miriam A. Lynn, Zelalem A. Mekonnen, Arthur Eng Lip Yeow, Pablo García-Valtanen, (unknown), Jason Gummow, Catherine Ferguson, Stephanie O’Connor, Benjamin Reddi, Pravin Hissaria, David Shaw, Chuan Kok Lim, Jonathan Gleadle, Michael R. Beard, Simon C. Barry, Branka Grubor‐Bauk, David J. Lynn	187
19	Whole-Genome Sequencing of SARS-CoV-2 from Quarantine Hotel Outbreak 2021 ·Emerging infectious diseases ·Lex E.X. Leong, Julien Soubrier, Mark Turra, (unknown), (unknown), Karin S. Kassahn, Geoff Higgins, Tom Dodd, Robert Hall, Katina D’Onise, Nicola Spurrier, Ivan Bastian, Chuan Kok Lim	7
20	Mycobacterial inactivation protein extraction protocol for matrix-assisted laser desorption ionization time-of-flight characterization of clinical isolates 2018 ·International Journal of Mycobacteriology ·(unknown), Chuan Kok Lim, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact